Exploring the landscape of symptom-specific inflammatory cytokines in post-COVID syndrome patients
Authors:
Open Access
- 22 November 2024
- journal article
- research article
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 24 (1) , 1-13
Abstract
Post-COVID syndrome (PCS) is characterized by a polymorphism of symptoms with hypothetical pathophysiological mechanisms. Here, we aimed to analyze the profile of inflammatory cytokines in patients with PCS and to study the relationship between this profile, the clinical symptoms as well as the endothelial function in PCS. Our analytical study involved all eligible patients (n = 66) with PCS included from April 2021 to December 2021. The serum concentration of cytokines IFN-γ, IL-1α, IL-1β, IL-6, IL-8, IL-10, IL-12p70, IL-27, IP-10, MCP-1 and TNF-α was quantified by flow cytometry. Endothelial function was explored by assessing microvascular flow and reactivity using thermal probes. A comparative study was carried out according to the presence of each PCS symptom. The average age of our patients was 55.9 ± 16.2 years. The sex ratio was 0.69. Forty-one patients (62%) presented with a severe form of acute infection. The most frequently reported symptoms were dyspnea (67%), fatigue (50%), and memory problems (32%). Fifty-seven patients (86%) had endothelial dysfunction. The majority of patients had increased levels of IP-10 (100%), IL-8 (95%), IFN-γ (95%), MCP-1 (80%), and TNF-α (70%). The serum concentration of IL-10 was below the threshold of quantification in 89% of subjects. The severe form of acute infection was associated with elevated IL-10, MCP-1, and IL-27. Increased IL-6 and IL-27 levels were associated with fatigue while IL-8 concentrations were higher in patients who reported dyspnea. Elevation of IL-8 level was more common in patients with profound impairment of endothelial function. Our results further support the presence of endothelial dysfunction in PCS and show an elevation of pro-inflammatory cytokines with a downmodulation of the IL-10- anti-inflammatory response. In addition, immuno-clinical phenotypes emerge, such as an inflammatory profile mediated by IL-6 and IL-27 in fatigue and IL-8 in dyspnea. The identification of immuno-clinical phenotypes would allow a better understanding of the pathophysiology of PCS symptoms.Keywords
This publication has 53 references indexed in Scilit:
- Immune modulation of learning, memory, neural plasticity and neurogenesisBrain, Behavior, and Immunity, 2011
- Evidence for a cytokine model of cognitive functionNeuroscience & Biobehavioral Reviews, 2009
- Discovery and Biology of IL-23 and IL-27: Related but Functionally Distinct Regulators of InflammationAnnual Review of Immunology, 2007
- Endothelial Cells Are Main Producers of Interleukin 8 through Toll-Like Receptor 2 and 4 Signaling during Bacterial Infection in Leukopenic Cancer PatientsClinical and Vaccine Immunology, 2003
- Effects of intrahippocampal CT105, a carboxyl terminal fragment of β‐amyloid precursor protein, alone/with inflammatory cytokines on working memory in ratsJournal of Neurochemistry, 2002
- Arrhythmogenic right ventricular cardiomyopathyJACC, 2001
- Preventive actions of a synthetic antioxidant in a novel animal model of AIDS dementiaBrain Research, 1998
- Inflammatory Cytokines in Patients With Persistence of the Acute Respiratory Distress SyndromeAmerican Journal of Respiratory and Critical Care Medicine, 1996
- The Association between Mortality Rates and Decreased Concentrations of Interleukin-10 and Interleukin-1 Receptor Antagonist in the Lung Fluids of Patients with the Adult Respiratory Distress SyndromeAnnals of Internal Medicine, 1996
- Neurobehavioral Alterations in Developing Transgenic Mice Expressing TNF-α in the BrainBrain, Behavior, and Immunity, 1996